<SEC-DOCUMENT>0001104659-19-075843-index.html : 20191226 <SEC-HEADER>0001104659-19-075843.hdr.sgml : 20191226 <ACCEPTANCE-DATETIME>20191226060553 ACCESSION NUMBER: 0001104659-19-075843 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20191220 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191226 DATE AS OF CHANGE: 20191226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC. CENTRAL INDEX KEY: 0000318306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 830221517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15771 FILM NUMBER: 191308092 BUSINESS ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 646-813-4701 MAIL ADDRESS: STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC DATE OF NAME CHANGE: 20140922 FORMER COMPANY: FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960209 FORMER COMPANY: FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>tm1927376d1_8-k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: tm1927376d1_8-k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tm1927376d1_ex99-1.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: tm1927376d1_ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>tm1927376d1_ex99-2.htm <DESCRIPTION>EXHIBIT 99.2 <TEXT> Document 3 - file: tm1927376d1_ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>logo.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: logo.jpg
</DOCUMENT> </SEC-DOCUMENT>